BIOMAT Database Logo BIOMAT Database Logo

Alkenyl substituted bicyclic nucleoside analogues retain nanomolar potency against Varicella Zoster Virus. 2009

Christopher McGuigan, and Olivier Bidet, and Marco Derudas, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini
Welsh School of Pharmacy, Cardiff University, Redwood Building, King Edward VII Avenue, Cardiff CF10 3NB, UK. mcguigan@cardiff.ac.uk

Novel alkenyl substituted aryl bicyclic furano pyrimidines have been prepared and evaluated in vitro against Varicella Zoster Virus (VZV). The para-substituted analogues retain the nanomolar potency we have reported for p-alkyl analogues, while the ortho- and meta-alkenyl systems lose 3-4 orders of potency.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014645 Herpesvirus 3, Human The type species of VARICELLOVIRUS causing CHICKENPOX (varicella) and HERPES ZOSTER (shingles) in humans. Chickenpox Virus,Herpes zoster Virus,Ocular Herpes zoster Virus,VZ Virus,Varicella-Zoster Virus,HHV-3,Herpesvirus 3 (alpha), Human,Herpesvirus Varicellae,Human Herpesvirus 3,Chickenpox Viruses,Herpes zoster Viruses,VZ Viruses,Varicella Zoster Virus,Varicella-Zoster Viruses,Varicellae, Herpesvirus
D019086 Bridged Bicyclo Compounds, Heterocyclic Heterocyclic compounds that contain two rings that share two non-adjacent atoms in common. Bicyclo Compounds, Heterocyclic,Heterocyclic Cpds, Bicyclic,Bicyclic Heterocyclic Compounds,Heterocyclic Bicyclo Compounds,Bicyclic Heterocyclic Cpds,Heterocyclic Compounds, Bicyclic

Related Publications

Christopher McGuigan, and Olivier Bidet, and Marco Derudas, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini
Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus.
December 2007, The Journal of antimicrobial chemotherapy,
Christopher McGuigan, and Olivier Bidet, and Marco Derudas, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini
Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus.
August 1997, Antiviral research,
Christopher McGuigan, and Olivier Bidet, and Marco Derudas, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini
Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication.
July 2002, The Journal of antimicrobial chemotherapy,
Christopher McGuigan, and Olivier Bidet, and Marco Derudas, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini
Potent and selective inhibition of varicella-zoster virus (VZV) by nucleoside analogues with an unusual bicyclic base.
November 1999, Journal of medicinal chemistry,
Christopher McGuigan, and Olivier Bidet, and Marco Derudas, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini
2'-Fluorosugar analogues of the highly potent anti-varicella-zoster virus bicyclic nucleoside analogue (BCNA) Cf 1743.
November 2009, Bioorganic & medicinal chemistry letters,
Christopher McGuigan, and Olivier Bidet, and Marco Derudas, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini
Highly potent and selective inhibition of varicella-zoster virus replication by bicyclic furo[2,3-d]pyrimidine nucleoside analogues.
May 2003, Medicinal research reviews,
Christopher McGuigan, and Olivier Bidet, and Marco Derudas, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini
Bicyclic nucleoside inhibitors of varicella-zoster virus: 5'-chloro and 3'-chloro derivatives.
January 2003, Nucleosides, nucleotides & nucleic acids,
Christopher McGuigan, and Olivier Bidet, and Marco Derudas, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini
Comparison of the selectivity of anti-varicella-zoster virus nucleoside analogues.
January 1995, Microbiology and immunology,
Christopher McGuigan, and Olivier Bidet, and Marco Derudas, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini
Metabolic and pharmacological characteristics of the bicyclic nucleoside analogues (BCNAs) as highly selective inhibitors of varicella-zoster virus (VZV).
January 2003, Nucleosides, nucleotides & nucleic acids,
Christopher McGuigan, and Olivier Bidet, and Marco Derudas, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini
Dipeptidyl peptidase IV-activated prodrugs of anti-varicella zoster virus bicyclic nucleoside analogues containing different self-cleavage spacer systems.
September 2012, ChemMedChem,
Copied contents to your clipboard!